APICES attend ESMO 2024 Congress
Our team at APICES CRO will be attending the ESMO Congress 2024 in Barcelona from September 13th to 17th!
Read more
The AEMPS includes bioequivalence studies in the accelerated CTIS procedure (fast-track)
The Spanish Agency for Medicines and Health Products (AEMPS) has expanded its accelerated evaluation process (fast-track), including bioequivalence studies. Interested sponsors must contact AEMPS before submitting the application to benefit from this process. This email should include the…
CTIS fast-track: AEMPS accelerated evaluation process
The Spanish Agency for Medicines and Health Products (AEMPS) has introduced an accelerated evaluation process (fast-track) to enhance Spain’s appeal for research on innovative medicines. This process will reduce the timelines for studies meeting the following criteria: Interested…
CLINICAL TRIALS APPROVAL IN EUROPE. APICES EXPERIENCE WITH CTIS
The Clinical Trials Information System (CTIS) is the online system for the regulatory submission, authorization, and supervision of clinical trials in the European Union and the European Economic Area. CTIS is the single entry point for clinical trials in…
Acknowledgement for APICES collaboration in BEATcc study published in “The Lancet”
This month, we want to share the acknowledgment that APICES has received in the recent publication of an international clinical trial, titled “Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase…
Acknowledgement for APICES collaboration in IMANOL study published in “Cancers”
This month, we want to share the acknowledgment that APICES has received in the recent publication titled “Phase II Trial Evaluating Olaparib Maintenance in Patients with Metastatic Castration-Resistant Prostate Cancer Responsive or Stabilized on Docetaxel Treatment: SOGUG-IMANOL Study”, published…
Acknowledgement for APICES collaboration in COMISH study published in “Clinical and Translational Oncology”
This month, we want to share the acknowledgment that APICES has received in the recent publication of COMISH study titled: “Real-world study on microsatellite instability and mismatch repair deficiency testing patterns among patients with metastatic colorectal cancer in…
Acknowledgement for APICES collaboration in GREKO study published in “Clinical and Translational Oncology”
We want to share the acknowledgment that APICES has received in the recent publication titled “Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian…
Clinical Operations in Oncology Trials Europe 2022
Clinical Operations in Oncology Trials Europe 2022 APICES is actively participating in the upcoming CLINICAL OPERATIONS IN ONCOLOGY TRIALS EUROPE 2022 congress in Zurich. In the following link you can access the agenda. Clinical Operations in Oncology Trials…
Acknowledgement for APICES collaboration in FDO-LMA-2016-01 study published in “Medicine International”
Acknowledgement for APICES collaboration in FDO-LMA-2016-01 study published in “Medicine International” This month, we want to share the acknowledgment that APICES has received in the recent publication titled “Biomarker-driven phase IB clinical trial of OPB-111077 in acute myeloid…
